Dr. Herbert David Aronow, MD

Dr. Aronow practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Aronow's NPI, 1235106766, was assigned on March 3, 2006. Dr. Aronow graduated from University Of Michigan Medical School in 1994. Dr. Aronow holds Michigan license 4301063695.

Dr. Aronow's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Aronow's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Aronow is also affiliated with Henry Ford West Bloomfield Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Aronow to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aronow practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Aronow's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Aronow is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Aronow's licenses on file in 4 states: Michigan, Rhode Island, Pennsylvania and Ohio.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Aronow treats.

CMS data shows 213 Medicare services from Dr. Aronow across 6 procedure codes in 2024, for 101 Medicare patients. Medicare paid $12,949 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Aronow in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aronow's median patient age at 75, with 32% women.

In 2024, Dr. Aronow wrote 200 Medicare Part D claims for 44 patients. 82% of them were for generic drugs. CMS names the drug for 107 of them, across 5 drugs with 11 or more claims each, at $1,505 in total drug cost. In 2023, CMS named 29 claims across 1 drug.

Dr. Aronow accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 244 papers to Dr. Aronow, published from 2005 to 2025. 2020 was the busiest year, with 35. The most frequent topics are Peripheral Arterial Disease, Endovascular Procedures and Percutaneous Coronary Intervention. Dr. Aronow has published most often in Am J Cardiol. Dr. Aronow's most frequent co-authors are Dhaval Sanjeev Kolte, MBBS, PhD, Michael Ritt Jaff, DO and Peter Andrew Soukas, MD.

Dmand AI links Dr. Aronow to 19 clinical trials, 2 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Carotid Artery Diseases, Peripheral Arterial Disease and Peripheral Vascular Diseases. Abbott Medical Devices sponsors the most, 4. Open Payments lists research payments to Dr. Aronow that name 2 trials.

CMS Open Payments shows 91 general payments to Dr. Aronow from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Novartis Pharmaceuticals Corporation paid the most, $5,760. It also lists 5 research payments totaling $1,400 in 2016, naming 2 clinical trials.

Dmand AI lists 4 awards for Dr. Aronow, most recently CMS Stage 1 EHR in 2013. Dr. Aronow serves on ACC PVD Committee and Board of Trustees SVM.

Dr. Aronow graduated from University Of Michigan Medical School in 1994. Dr. Aronow is a member of ACC.

Dr. Aronow is in network with 13 carriers, including Health Alliance Plan, Priority Health and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.